Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Proopiomelanocortin pathway is a biological pathway centered around the precursor protein proopiomelanocortin (POMC). POMC is processed into several peptides, including adrenocorticotropic hormone (ACTH), melanocyte-stimulating hormones (α-, β-, and γ-MSH), and β-endorphin. These peptides play critical roles in regulating stress response, energy balance, skin pigmentation, and pain relief. The pathway is crucial for maintaining glucose homeostasis and body weight, and it serves as a therapeutic target for obesity and related metabolic disorders.
Regulation of melanocortin receptors to influence energy balance and hormone secretion
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proopiomelanocortin pathway (POMC pathway).